Citation: | JIANG Hai-tao, HUANG Zuo-an, HUANG Dan-dan, XIANG Jian-jian, WANG Wu-ke, CHEN Yun-jie. The Mechanism study of the promotion of photodynamic therapy combined with NS-398 on the apoptosis of bile duct cancer cells QBC939 through inhibiting Bcl-2[J]. Chinese Journal of General Practice, 2021, 19(2): 193-197. doi: 10.16766/j.cnki.issn.1674-4152.001765 |
[1] |
OLIVEIRA I S, KILCOYNE A, EVERETT J M, et al. Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management[J]. Abdom Radiol, 2017, 42(6): 1637-1649. doi: 10.1007/s00261-017-1094-7
|
[2] |
熊永福, 杨刚, 李强, 等. 胆管癌相关多原发癌临床特点及预后分析[J/CD]. 中华肝脏外科手术学电子杂志, 2018, 7(5): 396-401. doi: 10.3877/cma.j.issn.2095-3232.2018.05.012
|
[3] |
邵子雨, 王许安, 刘颖斌. 肝内胆管癌的治疗现状及展望[J]. 浙江临床医学, 2019, 21(8): 1026-1028. https://www.cnki.com.cn/Article/CJFDTOTAL-ZPWL200102000.htm
|
[4] |
王葵, 沈锋. 肝内胆管癌的诊治进展[J]. 肝胆外科杂志, 2019, 27(1): 1-6. https://www.cnki.com.cn/Article/CJFDTOTAL-GDWZ201901001.htm
|
[5] |
刘金龙, 董家鸿. 肝门胆管癌临床治疗进展[J]. 河北医学, 2015, 21(6): 1005-1008. doi: 10.3969/j.issn.1006-6233.2015.06.047
|
[6] |
ZHU A X. Future directions in the treatment of cholangiocarcinoma[J]. Best Pract Res Clin Gastroenterol, 2015, 29(2): 355-361. doi: 10.1016/j.bpg.2015.02.010
|
[7] |
邹晓平, 丁希伟. 肝门部胆管癌的诊治进展及展望[J]. 中华消化杂志, 2018, 38(3): 151-154. doi: 10.3760/cma.j.issn.0254-1432.2018.03.003
|
[8] |
CHEN Y J, JIANG H T, CAO J Y. Influence of photodynamic therapy on apoptosis and invasion of human cholangiocarcinoma QBC939 cell line[J]. Chin Med Sci J, 2015, 30(4): 252-259. doi: 10.1016/S1001-9294(16)30009-8
|
[9] |
姜海涛, 陈云杰, 陆萍, 等. 选择性环氧合酶-2抑制剂NS-398和二十二碳六烯酸联合促进胆管癌QBC939细胞的凋亡[J]. 中华肝胆外科杂志, 2017, 23(8): 550-552. doi: 10.3760/cma.j.issn.1007-8118.2017.08.014
|
[10] |
姜海涛, 周惟, 毛联钢, 等. 二十二碳六烯酸联合选择性环氧合酶-2抑制剂NS-398对人胆管癌QBC939细胞凋亡的影响[J]. 中华肝胆外科杂志, 2018, 24(5): 336-340. doi: 10.3760/cma.j.issn.1007-8118.2018.05.013
|
[11] |
YAO C P, CAO X J, FU Z, et al. Boschniakia Rossica Polysaccharide Triggers Laryngeal Carcinoma Cell Apoptosis by Regulating Expression of Bcl-2, Caspase-3, and P53[J]. Med Sci Monit, 2017, 23: 2059-2064. doi: 10.12659/MSM.901381
|
[12] |
GONG H, CHAO Y, XIANG J, et al. Hyaluronidase to enhance nanoparticle-based photodynamic tumor therapy[J]. Nano Lett, 2016, 16(4): 2512-2521. doi: 10.1021/acs.nanolett.6b00068
|
[13] |
SHI X, ZHANG C Y, GAO J, et al. Recent advances in photodynamic therapy for cancer and infectious diseases[J]. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2019: e1560. doi: 10.1002/wnan.1560
|
[14] |
陈越, 郑军, 谭潇. 光动力疗法在肿瘤治疗中的研究进展[J]. 实用医学杂志, 2019, 35(16): 2517-2521. doi: 10.3969/j.issn.1006-5725.2019.16.001
|
[15] |
LAN M, ZHAO S, LIU W, et al. Photosensitizers for photodynamic therapy[J]. Advanced Healthcare Materials, 2019, 8(13): 1900132. doi: 10.1002/adhm.201900132
|
[16] |
陈云杰, 姜海涛, 王天飞, 等. DHA和NS-398联合对人胆管癌QBC939细胞的抑制作用[J]. 中华全科医学, 2017, 15(11): 1860-1862, 1910. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201711013.htm
|
[17] |
欧阳国庆, 刘志鹏, 熊力, 等. 原卟啉介导的光动力疗法对结肠癌HCT116细胞的杀伤和促凋亡作用及其机制[J]. 中南大学学报(医学版), 2017, 42(8): 874-881. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYD201708002.htm
|
[18] |
姜海涛, 曹景玉. 光动力疗法在胆管癌治疗中的研究进展[J]. 中国普外基础与临床杂志, 2015, 22(5): 633-636. https://www.cnki.com.cn/Article/CJFDTOTAL-ZPWL201505035.htm
|
[19] |
郝兴, 刘建生, 陈博艺, 等. 选择性环氧合酶-2抑制剂塞来昔布抗肿瘤作用机制的研究进展[J]. 中国现代医生, 2016, 54(34): 157-160. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS201634047.htm
|
[20] |
姜海涛, 张顺, 任燕萍, 等. NS-398和DHA联合抑制β-catenin、c-myc对胆管癌QBC939细胞凋亡的影响[J]. 中华普通外科杂志, 2018, 33(5): 416-419. doi: 10.3760/cma.j.issn.1007-631X.2018.05.015
|